Ignite Creation Date:
2024-05-06 @ 3:04 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04513847
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2020-08-12
Brief Title:
PsoVac Educational Needs re Vaccines for Biologic Patients With Psoriasis
Sponsor:
Dermatrials Research
Organization:
Dermatrials Research
Study Overview
Official Title:
PsoVac A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine if there is a need for further education on vaccines with psoriasis patients who are on a biologic In regards to the COVID-19 it is important that psoriasis patients - whether on a biologic or not - understand whether they can have certain vaccines That will depend on the type of vaccine that becomes available
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None